FDA Investigator Anjali Shukla, PhD

Anjali Shukla, PhD has inspections in 5 countries as of 20 Jul 2023. Anjali Shukla, PhD has collaborated with a combinined 1905 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
5
Last Inspection Date:
20 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100008967
Country:
United States of America, Switzerland, Austria, India, Malaysia
Co-Investigator(s):
Ademola O Daramola, Alice S Tsao, Amy Devlin, PhD, Anastasia G Lolas, Andrea Siegel, PhD, Bo Chi, PhD, Brooke K Higgins, Bruce H Mccullough, Carla J Lundi, Chaltu N Wakijra, Charanjeet Jassal, Charles I Ann, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Daniel J Lahar, Daniel Lahar, David M Beltran, Deborah Schmiel, PhD, Don H Bark, PhD, Donald C Obenhuber, PhD, Edmund F Mrak, Jr, Eileen A Liu, Frances Namuswe, PhD, Gwyn G Dickinson, Hamet M Toure, PharmD MPH, Hamet Toure, PharmD MPH, Jee Chung, PhD, Jeffrey D Meng, Jennifer C Adams, Jennifer M Gogley, Jennifer Swisher, PhD, Jonathan W Chapman, Jose E Melendez, DDC, Jose M Cayuela, Kalavati Suvarna, PhD, Katherine D Adams, Kathy Lee, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Laura Fontan, MS, LCDR Debra Emerson, Linda F Murphy, Linda M Cheny, LT Richard A Lyght, Luis A Dasta, Madushini Dharmasena, PhD, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marion Michaelis, Marjorie A Shapiro, PhD, Mary E Farbman, PhD, Maryam Tabatabaie, Mei Chiung J Huang, Merry Christie, PhD, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Mihaly S Ligmond, Mra B Kamberem, Muralidhara B Gavini, PhD, Nebil A Oumer, Patty P Kaewussdangkul, Paul L Bellamy, Peter Adams, PhD, Rachel C Harrington, Randy L Self, Reba A Gates, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert C Coleman, Roger F Zabinski, Rong Guo, Santos E Camara, Scott R Nichols, PhD, Seneca D Toms, Shadia Zaman, PhD, Shawn E Larson, Shawn R Gould, Sidney B Priesmeyer, Steven E Bowen, PhD, Susan M Jackson, Susanne M Richardson, MSc RAC ELS, Thomas A Peter, Thuy T Nguyen, LCDR, Thuy Y Nguyen, Travis S Bradley, Vidya B Pai, Vlada Matusovsky, Wayne E Seifert, William Hallett, PhD, Xiaokuang Lai, PhD, Xiaoping Guan, Xiaoshi Wang, Yetao Jin, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Anjali Shukla, PhD's Documents

Publish Date Document Type Title
March, 2019 FDA 483 Biocon Limited - Form 483, 2019-03-05
August, 2022 FDA 483 BIOCON SDN.BHD. - Form 483, 2022-08-30
September, 2018 FDA 483 Novartis Pharma Stein AG - Form 483, 2018-09-21
January, 2020 FDA 483 Response Human Genome Sciences, Inc. - Form 483R, 2020-02-18
January, 2020 EIR Human Genome Sciences, Inc. - EIR, 2020-01-29
October, 2017 FDA 483 Sandoz GmbH - Form 483, 2017-10-13
January, 2020 FDA 483 Human Genome Sciences, Inc. - Form 483, 2020-01-29

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more